WHO’s approval for Covaxin likely this month

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China's Sinopharm and Oxford-AstraZeneca for emergency use.

By: PTI
New Delhi | Updated: September 14, 2021 05:35 PM IST

1 min read

The development is significant as India is just one step away from a Covid-19 vaccine being formally approved for children above the age of 2 years. (Express photo: Deepak Joshi)

The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

This story requires a subscription

Select a plan and use DIWALI10 code to get 10% extra off

POPULAR

EXPRESS EDGE

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹133/month

Best for UPSC aspirants

This story requires a subscription

Select a plan and use DIWALI10 code to get 10% extra off

POPULAR

EXPRESS EDGE

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹133/month

Best for UPSC aspirants

Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

“The WHO approval for Covaxin is likely this month,” an official source said.

The Centre had told Rajya Sabha in July that all documents required for the WHO’s Emergency Use Listing (EUL) have been submitted by Bharat Biotech as of July 9, and the global health body had commenced the review process.

From the homepage